chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tightness in chest difficult to take a deep breath; Burning in upper arm; very sore for 2 full days; dry mouth for 2 weeks; high anxiety level; tightness in chest difficult to take a deep breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01Oct2021 19:15 (Lot number: 3013586) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing). Concomitant medication(s) included: LOSARTIN; ROSUVASTATIN. Past drug history included: Percocet, reaction(s): "known allergies : Percocet". The following information was reported: DYSPNOEA (non-serious), CHEST DISCOMFORT (non-serious) all with onset 02Oct2021 05:00, outcome "recovered with sequelae" and all described as "tightness in chest difficult to take a deep breath"; BURNING SENSATION (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "Burning in upper arm"; PAIN (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "very sore for 2 full days"; DRY MOUTH (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "dry mouth for 2 weeks"; ANXIETY (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "high anxiety level". Therapeutic measures were not taken as a result of dyspnoea, burning sensation, pain, dry mouth, anxiety, chest discomfort.  Additional information: Patient did not receive any other vaccine in four weeks. Did not experience COVID prior vaccination, not tested COVID post vaccination and no treatment received.  No follow-up attempts are possible. No further information is expected.
Information has been received form a physician concerning a 28 year old female who in 2003 was vaccinated with a series of varicella virus vaccine live. It was reported that a recent titer did not show full seroconversion.  The patient sought unspecified medical attention. There was no product quality complaint involved. Additional information has been requested.
I spoke to the pharmacist at Pfizer. He stated the manufacturer is unable to determine clinically if the expired dose given is stable for immunity . I was advise to reach out to Supply Chain Quality Team as they will  have more information regarding this issue . I asked for Supply Chain Quality Team phone number and was advised they can only be reached by email. The pharmacist stated he will be sending me an email with their information. Once I receive their contact info I will reach out to their team via email. I will contact the patient as soon as I find out from the Supply Chain Quality Team if the dose needs to be repeated. I was also advised to report this vaccine administration error to the CDC.  I have created this for the above patients. I was advised to report the immunization error to VAERS once I notify the patients.
The first problem was the ringing in my ears that kept getting louder.   My family all noticed that I wasn't acting normal.  I went to the buffalo hospital emergency room multiple times as my head was on fire.  I couldn't sleep.  The headaches were worse every day.  My blood pressure was increasing.  It felt like something was crawling around inside my skull.
Initial case received on 17 October 2014 from a customer. It pertains to one of two events experienced by the consumer; the other event is captured in case number 2014SA144926. An elderly male patient (date of birth and age not reported), with no reported medical history and no reported concomitant medication, experienced flu 2 months after he received a dose of flu vaccine. The batch number, date, site and route of administration were not reported. He did not have any testing to determine the strain. He was treated with TAMIFLU (doses and dates not reported). The outcome of the event was not reported. On the same day, it was reported by the same reporter that, two years later, the patient received another shot of influenza vaccine and reported a non-serious adverse event for which details are tracked in the linked case 2014SA144926. Documents held by sender: none.
Was not feeling well one month after vaccine. Had chest pains beginning in July of 2021. Did not go to doctor. Died suddenly on July 11th . It will be 6-9 months for autopsy results. Appeared to be sudden heart attack.
Case number PHEH2015US001341 is an initial spontaneous report from a consumer received on 14 Jan 2015. This report refers to a female patient of an unknown age. Her vaccination history included FLUVIRIN vaccine (batch number: not reported) on an unknown date and it was well tolerated. She never experienced headache or treated for headache. The patient was vaccinated with FLUVIRIN (batch number: 1413101) on 22 Sep 2014. On 23 Sep 2014, she experienced headache which continued for 3 months. She underwent numerous tests from CT, MRI of brain and lumbar puncture (results: not provided) and had 3 trips to emergency room. The outcome of the event reported as ongoing. The seriousness of the event was not reported. Her physician stated that as the event occurred 24 hours after vaccination, it was related to the vaccine.
headache; uncomfortable stomach; muscle pain presented in his hips.; Felt cold; shivering; Temperature read 98.3.  At 5:00 am his temperature read 99.7; First dose in February 2020; Soreness, redness and rash at the injection site; Redness and rash at the injection site; Rash at the injection site; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in February 2020.).   On 27th October 2020 09:00, the patient received the 9th dose of Shingrix .5 ml. In October 2020, less than a week after receiving Shingrix and an unknown time after starting Aspirin + Caffeine + Salicylamide, the patient experienced injection site pain, injection site erythema and injection site rash. On 27th October 2020, the patient experienced muscle pain, feeling cold, shivering, low grade fever and drug dose administration interval too long. On 28th October 2020, the patient experienced headache and stomach discomfort. The patient was treated with acetylsalicylic acid + caffeine + salicylamide (Aspirin + Caffeine + Salicylamide). In October 2020, the outcome of the muscle pain, feeling cold, shivering, headache and stomach discomfort were recovered/resolved. On 28th October 2020, the outcome of the low grade fever was recovered/resolved. On an unknown date, the outcome of the injection site pain, injection site erythema and injection site rash were not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the muscle pain, feeling cold, shivering, low grade fever, headache, stomach discomfort, injection site pain, injection site erythema and injection site rash to be related to Shingrix.  Additional details were reported as follows: The patient received the vaccine in the left arm and by the afternoon, muscle pain presented in his hips.  That evening he felt cold and was shivering and his temperature read 98.3 degree F at 5:00 am his temperature read 99.7.  He took aspirin and it came down.   A headache and uncomfortable stomach presented the next day.   All symptoms had resolved till the time of reporting except soreness, redness and rash at the injection site.   The reporter consented to follow up.
Vaccine administered one day after the Beyond Expiration date of 02/13/2013.
Around 10:00pm, I developed a fever and chills. The chills lasted for about two hours until I was just left with the fever until I fell asleep around 2:00am. The next day, I woke up with neck and head pain which disappeared after a couple more hours of rest until 11:00am. Afterward, that day, I had a slight headache which eventually disappeared sometime late in the evening around 9pm. The following day after the shot (second day later), I felt completely normal.
Patient woke up with a 102.2 fever. Patient was very tired, weak and dizzy. Motrin helped symptoms and reduced the fever. Mother noted swelling at the injection site on Left arm.
Brachial neuritis characterized by pain in upper right arm ranging from moderate to severe beginning in Feb 2019. Pain continues in March 2019. Right arm is supported with pillow on console while driving and at bedtime to aid sleep.
Patient became ill several hours after booster vaccination. Main complaint is nausea and uncontrollable vomiting, abdominal cramping. Patient was seen in ER on 12/17/21 and admitted for observation with diagnosis of ACUTE RENAL FAILURE, HYPONATREMIA, RHABDOMYOLYSIS, INTRACTABLE VOMITING. Released home and patient returned to ER on 12/18/21 with same symptoms. Patient readmitted for Observation.
Significant bruise (diameter of golf ball), cough, wheezing. No pain, warmth, swelling in arm.
headache, upset stomach, blurred vision and itchy eyes, trouble hearing in left ear, chronic hives, difficulty breathing, chest pain, burning and itching skin all over the upper half of the body
Within 8 hours of injection I got very sick.  Fever went to 103 degrees, headache, severe chills and body aches.  Recovered in 48 hours.  Approximately 3 weeks later, I felt a lump and tenderness to the left of my pubic area.  I have since realized, the lump was a swollen lymph node and it disappeared after several days.  Then I felt pulsations and tingling on my left ovary which I eventually realized I was ovulating!  I've been in menopause for 4 years so I haven't felt that in 4 years.  My breasts became very tender and sore and I had faint (light pink) spotting.  This lasted several days.  2 weeks later, May 6th, I had menstrual cramps and faint pink spotting.  Although I haven't had a period in 3-4 years, I remember all the symptoms and it felt like I was getting my period.  To date, I did not get a menstrual flow.  This is a significant reaction in my opinion.
feeling uncomfortable; her arm is red/arm is hilarious red; her arm is sore; arm is puffy; has a slight temperature; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (feeling uncomfortable), ERYTHEMA (her arm is red/arm is hilarious red), PAIN IN EXTREMITY (her arm is sore), PERIPHERAL SWELLING (arm is puffy) and PYREXIA (has a slight temperature) in a 75-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     The patient never had COVID-19 positive test or diagnosis.  No medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. The patient had no other vaccine within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Drug allergy (Sulfa) and Penicillin allergy. Concomitant products included LOSARTAN POTASSIUM (LOSARTIN) and ATORVASTATIN for an unknown indication.    On 06-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feeling uncomfortable), ERYTHEMA (her arm is red/arm is hilarious red), PAIN IN EXTREMITY (her arm is sore), PERIPHERAL SWELLING (arm is puffy) and PYREXIA (has a slight temperature). At the time of the report, FEELING ABNORMAL (feeling uncomfortable), ERYTHEMA (her arm is red/arm is hilarious red), PAIN IN EXTREMITY (her arm is sore), PERIPHERAL SWELLING (arm is puffy) and PYREXIA (has a slight temperature) had not resolved.            Patient received the two primary series doses and a booster dose. The patient experienced a similar event in the past after receiving the vaccines. The treatment medication was not reported.   This case was linked to MOD-2022-656521, MOD-2022-656523, MOD-2022-656524 (Patient Link).   Reporter did not allow further contact
Signs and symptoms: moody, grumpy, short tempered, red and swollen injection site, diarrhea, rash.  Treatment: Tylenol, fluids, observe, cold pack to injection site.  4/22/08: mom reports only signs and symptoms now is slight redness injection site.
pt recv vax & exp sz;taken to ER & was told t103;bilateral ear infect;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 19Oct2023 at 02:00 as dose 1, single (Batch/Lot number: unknown) at the age of 67 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "obese" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing); "Allergies: bees" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Demerol, reaction(s): "Allergies: demerol". Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 3 (BOOSTER), MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 4 (BOOSTER), MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 5 (BOOSTER), MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Nov2023, outcome "recovered" (Nov2023) and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Nov2023) Positive, notes: Day 5: tested positive; (Nov2023) Negative, notes: Day 7: tested negative and was symptom free. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical Course: Patient received Paxlovid treatment from 08Nov2023 to 13Nov2023.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300381442 same patient, different event/drug;
Dizzy; vision started shaking; became very weak; felt sick; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Jun2021 at 13:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN) and essential oils (MANUFACTURER UNKNOWN) from unknown date for unknown indications. On 24Jun2021 at 15:30, a couple hours after receiving the vaccine, the patient became very weak and dizzy. It was the worst when she laid down. Her vision started shaking violently when she would then sit still at all for three to five minutes. It subsided, but she felt sick the rest of the day and the next morning. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event became very weak and dizzy. Her vision started shaking violently she would then sit still at all for three to five minutes, it subsided, but she felt sick the rest of the day and the next morning was recovered on 25Jun2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 64-year-old, adult patient of an unspecified gender. It was reported that, the FLUCELVAX QIVc vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 23-Oct-2018, the patient was administered FLUCELVAX QIVc [route of administration: intramuscular, anatomical location: left deltoid, batch number: 252230, expiry date: 31-May-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805420 was crossed linked to original case 201804863 due to same reporter.
24 hours after injection, patient had swelling, redness, warmth at injection site, tender to the touch, fever, chills, and overall discomfort. Patient hasn't taken anything for above symptoms. Patient still has bump (swelling), warmth and tender to the touch.
While administering patient's 1st dose, nurse attempted to push plunger. The vaccine sprayed-out of syringe onto nurse's hands and face. The needle stayed in patient's arm, leaving the syringe in 2 pieces. Floor lead notified. A second vaccine had to be given to patient at this time.
COLD SWEATS; MINOR SNIFFLES; FEVER; TIREDNESS; MUSCLES PAINS; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced cold sweats, minor sniffles, fever, tiredness, and muscles pains. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cold sweats, fever, tiredness, muscles pains and minor sniffles was not reported. This report was non-serious.
I had an increase in my blood pressure out of nowhere. Just started increasing up to 170 close to 180. That's when I told the nurse practitioner. They checked it and sent me to a heart specialist. He changed some of my medication to get it under control. Also had an increase in my blood sugar levels. My doctor had to increase my metformin to twice a day and added the Jardiance to get it under control. Before receiving the vaccine, I never had to take diabetes medication to control my sugar levels. I also have began to get cramps in my feet and calves.
Patient received Moderna Dose 1 on 3/5/2021 at BMH. Patient showed up to ETMG today and his first dose was not verified with Pharmacy or staff prior to administering Pfizer Dose 2.
Red, lumpy with black bruising on arm at injection site after 2nd day. Lumps and black bruising went away after first week but still have a red bull eye with scabbing at injection entrance after almost a month. Also injection site is itchy.
Pt. woke up with numb and tingling hands and feet. Symptoms grew worse and pt went to ED 10/19/2014. Negative CT scan, sent home to f/u with PCP, who advised f/u with neurologist. On 10/27/14, pt went back to PCP with c/o cont. numbness and tingling and increasing SOB with increasing joint pain and trouble ambulating.  Admitted to local hospital where lumbar puncture and EMG confirmed Guillain-Barre Syndrome. IV IG treatments given, after five days pt dc'd home.  As of the day of this report, pt has still not regained full feeling in hands and feet, still has pain in hands, shoulders, left arm, and lower back, still has occasional difficulty with full movement.
pt ran fever of 103 on 7SEP95;mom reports pt had 3 szs on 7SEP95 each sz lasted approx 1 min; pt was drowsy afterward but otherwise seemed to recover quickly & completely;mom has appt w/MD
My symptoms started with in 8 hours of receiving 2nd dose. I currently have severe fatigue, malaise, severe body aches, extreme chills and i have been having profuse sweating, my clothes r drenched in sweat. Headaches and have not been able to sleep at all overnight
A 16 year old female patient had received an intra-muscular injection of Typhim Vi on 19 Oct 05.  Within 15-20 minutes, she complained of headache and developed fever at 104.2 F. She was seen and evaluated by a NP and she received corrective treatment with Advil.  The fever decreased but the headache persisted.  The patient did not recovered.
Client lost consciousness about 5-8minutes after vaccines given around 3:15pm.   Code assist paged.  Dr. at bedside.  Patient lethargic but alert and talking to mom. Staff from present.  Pt stated she can't feel her legs. Bp 65/36.  She could feel Dr. touching legs.  Patient is moving arms and legs/holding mom's hand.  Pt had breakfast but no lunch.  Dr. with patient.  Pat eating some juice and crackers.  At 1547 patient propped up on wall eating crackers and drinking juice with mom.  1556-sitting up "feeling better but too tired to talk" per client (8 yo child).  BP 92/64 and pulse 73 at 1550.  Client discharged at 4pm with a bp of 99/69 and pulse of 78. RN
Tremors and convulsions in upper body.  Treated with Ativan at hospital.  Continues to suffer from minor tremors.   11/20/09:  ED Records, Discharge summary and hospital records received for dates of service 11/8/09 to 10/10/09.  Dx:  Probable psychogenic tremor.  Possible acute dystonic reaction,  Sinus disease.  Assessment: Presented with hives, shaking of whole body, ataxia when sitting up and development of violent dystonic movements of the neck and trunk and low back pain. Probable psychogenic tremor. Movements were fluctuating and distractable.  Pain controlled by Tylenol.  Tx: Cogentin, Benadryl, lorazepam and diazepam. IV fluids given.  Symptoms improved and he was discharged to home.  No work for one week.    ICD 9 Codes:  781.3, 781.0, 724.2.  11/30/09:  Discharge Summary and Medical records received for dates of service 11/6/09 to 11/7/09.  Final Dx:  Psychogenic movement disorder, anxiety, back pain.    Assessment:  Presents with back pain, spasms, and body tremors.  Fell from chair due to tremors.  Noted to have severe ataxia. Thought to be psychological malfunction.
He received Hib and Prevnar at 10 AM.  At 1230, Mother was holding infant in arms and states that his eyes popped open and he seemed to had a fixed stare for 1 minute. Then he had "convulsing" movements of arms and legs that lasted for 35 seconds.  Eyes rolled back in his head.  Episode lasted approx 35 seconds, then he resumed a fixed stare for 1 minute.  Then he cried and appeared responsive.  No fever.  He vomited once during episode.
Around 6:30 p.m. my skin started to burn all over my face begin to swell shortly after that my tongue and throat begin to swell I feel pressure on my chest I can barely breathe when I was put into the ambulance I passed out when I woke back up the symptoms seems to have gotten worse the EMT called in a head to the hospital and ask what to do she was told to give me an EpiPen as we got closer to the hospital I begin to shake and tremble uncontrollably that lasted for at least another 30 40 minutes after being admitted to the emergency room my diagnosis was anaphylaxis.